BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24500341)

  • 1. Epigenetic alterations in osteosarcoma: promising targets.
    Li B; Ye Z
    Mol Biol Rep; 2014 May; 41(5):3303-15. PubMed ID: 24500341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes in osteosarcoma.
    Cui J; Wang W; Li Z; Zhang Z; Wu B; Zeng L
    Bull Cancer; 2011 Jul; 98(7):E62-8. PubMed ID: 21708514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
    Morrow JJ; Khanna C
    Crit Rev Oncog; 2015; 20(3-4):173-97. PubMed ID: 26349415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN in osteosarcoma: Recent advances and the therapeutic potential.
    Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
    Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel molecular and metabolic aspects in osteosarcoma.
    Tsiambas E; Fotiades PP; Sioka C; Kotrotsios D; Gkika E; Fotopoulos A; Mastronikolis SN; Armata IE; Giotakis E; Ragos V
    J BUON; 2017; 22(6):1595-1598. PubMed ID: 29332359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.
    Sun C; Li S
    J Cell Mol Med; 2021 Apr; 25(7):3175-3181. PubMed ID: 33675132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RECQ DNA helicases and osteosarcoma.
    Lu L; Jin W; Liu H; Wang LL
    Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
    Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressing effects of miR451 in human osteosarcoma.
    Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
    Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRX1 hypomethylation in osteosarcoma metastasis.
    Lu J; Wang J
    Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
    Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
    Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
    Miao J; Wu S; Peng Z; Tania M; Zhang C
    Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in osteosarcoma via various signaling pathways.
    Han J; Shen X
    J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER-2 involvement in osteosarcoma.
    Gill J; Geller D; Gorlick R
    Adv Exp Med Biol; 2014; 804():161-77. PubMed ID: 24924174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.
    Mu X; Sultankulov B; Agarwal R; Mahjoub A; Schott T; Greco N; Huard J; Weiss K
    Clin Orthop Relat Res; 2014 Mar; 472(3):865-73. PubMed ID: 23761177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics of osteosarcoma.
    Bernardini G; Laschi M; Geminiani M; Santucci A
    Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
    Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
    J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical roles of lncRNAs in the development of osteosarcoma.
    Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M
    Biomed Pharmacother; 2021 Mar; 135():111217. PubMed ID: 33433358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.